MarketWatch
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
M
Source
MarketWatch
Read full article at MarketWatch
Opens original article in a new tab
Advertisement